Clindamycin as an antimalarial drug: review of clinical trials.
about
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malariaFosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malariaGenetic reconstruction of protozoan rRNA decoding sites provides a rationale for paromomycin activity against Leishmania and TrypanosomaIsoprenoid precursor biosynthesis offers potential targets for drug discovery against diseases caused by apicomplexan parasitesSulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections.Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.Antimalarial compounds in Phase II clinical development.Chemistry and biology of macrolide antiparasitic agents.Severe Malaria Complicated by G6PD Deficiency in a Pediatric Tanzanian Immigrant.In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium speciesClindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysis.Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malariaInadequate efficacy of a new formulation of fosmidomycin-clindamycin combination in Mozambican children less than three years old with uncomplicated Plasmodium falciparum malaria.Parasite plastids: approaching the endgame.The plastid-derived organelle of protozoan human parasites as a target of established and emerging drugs.Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplastUpdate on antimicrobial agents: new indications of older agents.Macrolides and associated antibiotics based on similar mechanism of action like lincosamides in malaria.Assessment of safety of the major antimalarial drugs.Update on clindamycin in the management of bacterial, fungal and protozoal infections.In Vivo Efficacy and Tolerability of Artesunate-Azithromycin for the Treatment of Falciparum Malaria in VietnamFR-900098, an antimalarial development candidate that inhibits the non-mevalonate isoprenoid biosynthesis pathway, shows no evidence of acute toxicity and genotoxicityHerbicidal properties of antimalarial drugs.Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy.New approaches in antimalarial drug discovery and development: a review.Transformation of saturated nitrogen-containing heterocyclic compounds by microorganisms.New insight-guided approaches to detect, cure, prevent and eliminate malaria.In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum.Mutasynthesis of lincomycin derivatives with activity against drug-resistant staphylococci.New medicines for malaria.Cytokine profile of Plasmodium falciparum-specific T cells in non-immune malaria patients.Characterization of N-demethyllincosamide methyltransferases LmbJ and CcbJ.Antimalarial interaction of quinine and quinidine with clarithromycin.Clindamycin phosphate scavenges hydroxyl radical.Impact of Sickle Cell Trait and Naturally Acquired Immunity on Uncomplicated Malaria after Controlled Human Malaria Infection in Adults in Gabon.Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites.Clindamycin hydrochloride and clindamycin phosphate: two drugs or one? A retrospective analysis of a spontaneous reporting system.
P2860
Q17485067-754E0711-1E46-4A38-A8A6-CA48AFDB3A57Q24680404-C90CE0D9-BB68-4FFF-9FD6-975FA2532DC8Q28478249-08CA5FF1-9E2D-491F-B7C2-F15B54113E55Q28727252-1099C71D-AFE0-4EB2-ACAA-11BDC7FAF5C6Q33589254-1E359413-B065-4849-8D7B-6F8B4F7F20C9Q33806574-290820A1-1CB5-44CB-970E-1FD3651FE217Q34456807-01B1A1C9-07B5-4574-A88C-B8DF4CEE08A4Q34904340-F53431F0-9A66-46AE-B0A1-8D410C796598Q35124138-17131001-CF51-47A0-8DF7-191937D71BEEQ35689416-E289AF3A-5550-4CA6-AE26-47CF4FB29208Q35759007-19142691-F407-4410-8714-1576E995B186Q35759028-0DF186A2-96BD-437C-86B4-6E9780DD42F9Q36018812-D770E407-990F-4308-9156-D887ACADDE46Q36052586-0D913E35-553F-4D36-AC8E-17ED85CC56C1Q36066272-0E290378-73A7-450C-952A-4BD6913CAFDDQ36093316-8B9EA4C2-E8E7-46F6-9DC8-93D16FA4FE30Q36095096-20265450-6C78-4BF2-B79B-5F65A1DA6C3DQ36222046-E3237BEB-2201-46F6-9014-6F0F8828DA4AQ36577718-5E5F15C3-DC0C-4856-B468-6FAF69C94C7FQ36945007-443E6CAA-8B27-496E-AA7E-3F4EF74B7E7DQ36967293-7017AC9E-D976-47EC-A011-BAF6BA977FF1Q37094433-14AD4DE1-4698-493E-B2A4-C49A620294E6Q37189932-CBDF77CC-F1E8-4D56-A3E0-2361498D5302Q37731378-87171EE8-E365-459A-AEE2-254A5F2E56F4Q37735182-8473E7C6-CF15-4217-8E46-7E9CE82B2E56Q38059380-9267AA99-7357-41E1-8C22-310E92F6B929Q38172427-369E6DC2-2F6B-4CAF-A996-BE64F1094437Q38260909-F8F06522-D551-4AA7-836B-F1BD002C268DQ39381330-0AF9483C-C725-48D6-9949-22EACCCC7997Q41812922-C7BDECA8-B65E-49B9-8F38-DDF6693CF619Q41936153-BE16EB70-0F84-4EFB-9F76-FF9D1660C40BQ44174178-C3B2C2DD-D084-43C9-B2BD-137407D29158Q44387963-90D9BF12-A85A-4465-912A-F2956DCED37DQ45907681-330CCB1F-259C-484A-81D7-DEE67DD11B10Q46910797-B7028F4B-EEE7-4678-90D7-C14D77169241Q47271937-77C6B65D-391E-4280-B081-5323A68192EBQ48015411-7A48A16B-D275-4228-A878-4AE48FF8A7F0Q48221168-65D26715-D288-449D-B3AE-8C30FCB20429
P2860
Clindamycin as an antimalarial drug: review of clinical trials.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clindamycin as an antimalarial drug: review of clinical trials
@nl
Clindamycin as an antimalarial drug: review of clinical trials.
@ast
Clindamycin as an antimalarial drug: review of clinical trials.
@en
type
label
Clindamycin as an antimalarial drug: review of clinical trials
@nl
Clindamycin as an antimalarial drug: review of clinical trials.
@ast
Clindamycin as an antimalarial drug: review of clinical trials.
@en
prefLabel
Clindamycin as an antimalarial drug: review of clinical trials
@nl
Clindamycin as an antimalarial drug: review of clinical trials.
@ast
Clindamycin as an antimalarial drug: review of clinical trials.
@en
P2860
P1476
Clindamycin as an antimalarial drug: review of clinical trials.
@en
P2860
P304
P356
10.1128/AAC.46.8.2315-2320.2002
P407
P577
2002-08-01T00:00:00Z